Preoperative C-reactive protein and textbook outcome following pancreaticoduodenectomy for pancreatic head adenocarcinoma

Table 1 Baseline characteristics of the overall cohort and comparison according to textbook outcome status

Variable	Total (n = 100)	TO (n = 53)	Non-TO (n = 47)	P value
Age, years	65.0 (56.8-70.2)	65.0 (54.0-71.0)	65.0 (60.0-69.5)	0.525
Sex				1.000
Male	61 (61.0)	32 (60.4)	29 (61.7)
Female	39 (39.0)	21 (39.6)	18 (38.3)
BMI, kg/m2	25.9 (23.3-28.1)	26.4 (23.6-28.1)	25.1 (23.2-27.2)	0.269
ASA score				0.700
I	5 (5.0)	3 (5.7)	2 (4.3)
II	83 (83.0)	45 (84.9)	38 (80.9)
III	12 (12.0)	5 (9.4)	7 (14.9)
CA19-9, U/mL	127.1 (29.6-371.3)	103.7 (17.6-294.0)	150.6 (42.6-413.7)	0.192
Preoperative CRP, mg/L	7.3 (2.1-22.4)	3.1 (1.2-8.8)	22.2 (6.9-38.5)	< 0.001
Preoperative albumin, g/L	33.8 (28.8-39.1)	34.8 (30.4-39.9)	32.0 (25.2-38.0)	0.057
Preoperative total bilirubin, mg/dL	1.7 (0.7-3.7)	1.3 (0.6-3.4)	2.0 (0.8-4.3)	0.215
Preoperative biliary drainage				0.681
Yes	64 (64.0)	35 (66.0)	29 (61.7)
No	36 (36.0)	18 (34.0)	18 (38.3)
Pylorus-preserving PD				1.000
Yes	41 (41.0)	22 (41.5)	19 (40.4)
No	59 (59.0)	31 (58.5)	28 (59.6)
Intraoperative transfusion				0.043
Yes	42 (42.0)	17 (32.1)	25 (53.2)
No	58 (58.0)	36 (67.9)	22 (46.8)

TO: Textbook outcome; BMI: Body mass index; ASA: American Society of Anesthesiologists; CA19-9: Carbohydrate antigen 19-9; CRP: C-reactive protein; PD: Pancreaticoduodenectomy.